Kura Oncology Stock (NASDAQ: KURA) stock price, news, charts, stock research, profile.
Open | $17.610 |
Close | $17.530 |
Volume / Avg. | 1.330M / 1.391M |
Day Range | 16.790 - 17.900 |
52 Wk Range | 7.410 - 24.170 |
Market Cap | $1.335B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 13.8% |
Days to Cover | 12.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kura Oncology (NASDAQ: KURA) through any online brokerage.
Other companies in Kura Oncology’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
The latest price target for Kura Oncology (NASDAQ: KURA) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 32.00 expecting KURA to rise to within 12 months (a possible 82.54% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Kura Oncology (NASDAQ: KURA) is $17.53 last updated April 19, 2024 at 4:29 PM EDT.
There are no upcoming dividends for Kura Oncology.
Kura Oncology’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Kura Oncology.
Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.